A new drug promising to reverse aging has been injected into a human body for the first time.
According to Life Biosciences, the first patient received an injection to reprogram cells and combat age-related diseases. Previously, this method was only tested on animals. Now, the so-called "fountain of youth" has been administered to a human.
Scientists will monitor the patient's condition and study initial changes. This first successful human trial could mark a new era in anti-aging therapy. The goal is to rejuvenate cells and improve DNA expression.
The injection was given to the eye of a patient with glaucoma. Over six months, scientists will assess efficacy and doctors will evaluate safety. This is a turning point in longevity science.
